340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Recapping a Momentous Year for 340B

 

Dec. 31, 2021– Today is the final day of what might be one of the most eventful years in the history of the 340B drug pricing program. Key developments in the 340B world stood out even amid all the news about a global pandemic, a change in leadership in Washington, and an uneasy economic climate. As we wrap up 2021 and look forward to a new year, we are reflecting on some of … [Read more...]

A Hospital Community United Against Threats to 340B

 

Dec. 20, 2021— Hundreds of safety-net hospitals are urging the federal government to escalate its efforts to stop a group of drug companies that are refusing to offer drug discounts that the federal 340B drug pricing program requires. Today, more than 800 hospitals participating in 340B sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra calling on the … [Read more...]

340B Transparency Efforts Uncovering More Drug Company Overcharges

 

Dec. 8, 2021– In the nearly three years since the Health Resources & Services Administration (HRSA) launched its 340B drug pricing program ceiling price website, 41 drug companies have acknowledged that they overcharged 340B hospitals, health centers, and clinics and would refund those affected. This contrasts with only seven such reports in the two years prior to the … [Read more...]

We Celebrate Rural Health Day by Protecting 340B

 

Nov. 18, 2021– The patient care mission of 340B hospitals serving rural areas of the U.S. takes on a special importance when one considers that in many cases, they are the only providers in a position to offer certain types of needed care. On this National Rural Health Day, we reflect on the crucial nature of the role rural hospitals play, the continuing challenges they face, … [Read more...]

Eli Lilly Again Reports Big Revenue Gains From 340B Denials

 

Nov. 1, 2021– The first drug company to deny 340B drug pricing program discounts to safety-net hospitals, health centers, and clinics saw its U.S. revenues jump 26% in the third quarter of 2021, thanks in part to the higher prices it is charging for diabetes drugs sold to 340B providers. In a public financial report, Eli Lilly said its third-quarter U.S. revenue totaled … [Read more...]

Seventh Drug Company Told It is Violating 340B Law

 

Oct. 12, 2021– Eight drug companies have restricted access to discounts to safety-net providers through the 340B drug pricing program on drugs dispensed at community-based pharmacies. Now the government officially has informed all but one of those companies that they are in violation of federal law and must restore the discounted pricing. The most recent recipient of a … [Read more...]

HHS Takes Vital Next Step Toward Ending 340B Pricing Denials

 

Oct. 1, 2021– The federal government has taken dramatic action to get drug companies to restore 340B pricing for outpatient prescription drugs dispensed by community pharmacies to patients of 340B hospitals. On Sept. 22, the Health Resources & Services Administration (HRSA) sent letters to six drugmakers informing them that the agency is asking the Office of Inspector … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health